Prenatal Alcohol Biomarker Study in Uruguay

Status Completed

Clinical Trial Summary

The purpose of this study is to examine the association between maternal alcohol use and newborn phosphatidylethanol (PEth) levels in their newborn.

Clinical Trial Description

The goal of the proposed research study is to examine the association between maternal alcohol use and newborn phosphatidylethanol (PEth) levels in their newborn children, in a country (Uruguay) where significant alcohol use is common during pregnancy. Maternal alcohol biomarker assays will include ethyl glucuronide (EtG) in hair and nails and PEth in blood obtained at the time of delivery. Newborn umbilical cord and routine 48 hour heel stick blood will be collected to assess newborn PEth levels. Maternal biomarker levels will be compared to patient self-reported alcohol use. This proposed design is a cross-sectional study that will include 1,800 women 18 years and older and their newborns. Women who are admitted to one of two selected public health care hospitals in Montevideo, Uruguay (Hospital Pereira Rossell and Servicio Medico Integral) for obstetrical care will be recruited to participate in the study. Power estimates suggest that 1,800 maternal/infant pairs will give us sufficient power (>90%) to estimate the predictive validity of this biomarker as a routine newborn screening test. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02600624
Study type	Observational
Source	Northwestern University
Contact
Status	Completed
Phase
Start date	August 18, 2016
Completion date	July 2019

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06163651` - Evaluating a One-Year Version of the Parent-Child Assistance Program	N/A
Active, not recruiting	`NCT00996528` - Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)	Phase 3
Completed	`NCT00164554` - Fetal Alcohol Syndrome/ARND Research Consortion	Phase 1/Phase 2
Completed	`NCT00164229` - Fetal Alcohol Syndrome: Socio-Cognitive Habilitation	Phase 1/Phase 2
Recruiting	`NCT05534568` - The Oklahoma Parent-Child Assistance Program	N/A
Recruiting	`NCT05385328` - Multisensorial Analysis of Human Activity for Diagnosis and Early Detection of Functional Limitations
Completed	`NCT01911299` - Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders	Phase 2
Terminated	`NCT00747630` - Evaluating the Efficacy of a Video Based Intervention to Educate Teen Moms About Fetal Alcohol Syndrome (FAS)	Phase 0
Recruiting	`NCT04332172` - Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy	N/A
Completed	`NCT00696085` - Fetal Alcohol Damage Prevention Study	N/A
Recruiting	`NCT00418262` - Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD	Phase 3
Completed	`NCT01149538` - Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure	Phase 1/Phase 2
Recruiting	`NCT03371641` - In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions	N/A
Completed	`NCT00164346` - Neurocognitive Habilitation for Children With Fetal Alcohol Syndrome (FAS)/Alcohol-Related Neurodevelopmental Disorder (ARND)	Phase 1/Phase 2
Completed	`NCT01994603` - Expansion to Interdisciplinary HIV Prevention in Women	N/A
Completed	`NCT00417794` - Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD	Phase 1
Completed	`NCT00244062` - Healthy Moms Alcohol Intervention	N/A
Recruiting	`NCT04395196` - RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure	Phase 2